Solid Biosciences (SLDB)
(Delayed Data from NSDQ)
$7.86 USD
-0.14 (-1.75%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.88 +0.02 (0.25%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Solid Biosciences Inc. [SLDB]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Solid Biosciences Inc.
Industry: Medical - Biomedical and Genetics
SGT-003?s Potential Solidified; Eyes on Year-End Clinical Readout; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Solid Biosciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Solid Biosciences Inc.
Industry: Medical - Biomedical and Genetics
Smooth Sailing Toward Year-End SGT-003 Readout ; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Solid Biosciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Solid Biosciences Inc.
Industry: Medical - Biomedical and Genetics
Capsid Validation of SGT-003 on the Heels of Peer''s Encouraging Interim Readout; Higher $16 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Solid Biosciences Inc.
Industry: Medical - Biomedical and Genetics
Recasting a SOLID Foundation; Initiate With Buy and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Solid Biosciences Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - Ever Evolving Genetic Medicines
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Solid Biosciences Inc.
Industry: Medical - Biomedical and Genetics
|